Literature DB >> 18840636

The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface.

T T Chung1, T R Webb, L F Chan, S N Cooray, L A Metherell, P J King, J P Chapple, A J L Clark.   

Abstract

CONTEXT: There are at least 24 missense, nonconservative mutations found in the ACTH receptor [melanocortin 2 receptor (MC2R)] that have been associated with the autosomal recessive disease familial glucocorticoid deficiency (FGD) type 1. The characterization of these mutations has been hindered by difficulties in establishing a functional heterologous cell transfection system for MC2R. Recently, the melanocortin 2 receptor accessory protein (MRAP) was identified as essential for the trafficking of MC2R to the cell surface; therefore, a functional characterization of MC2R mutations is now possible.
OBJECTIVE: Our objective was to elucidate the molecular mechanisms responsible for defective MC2R function in FGD.
METHODS: Stable cell lines expressing human MRAPalpha were established and transiently transfected with wild-type or mutant MC2R. Functional characterization of mutant MC2R was performed using a cell surface expression assay, a cAMP reporter assay, confocal microscopy, and coimmunoprecipitation of MRAPalpha.
RESULTS: Two thirds of all MC2R mutations had a significant reduction in cell surface trafficking, even though MRAPalpha interacted with all mutants. Analysis of those mutant receptors that reached the cell surface indicated that four of six failed to signal, after stimulation with ACTH.
CONCLUSION: The majority of MC2R mutations found in FGD fail to function because they fail to traffic to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840636      PMCID: PMC2635546          DOI: 10.1210/jc.2008-1744

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

Review 1.  Pharmacological chaperones: potential treatment for conformational diseases.

Authors:  Virginie Bernier; Monique Lagacé; Daniel G Bichet; Michel Bouvier
Journal:  Trends Endocrinol Metab       Date:  2004-07       Impact factor: 12.015

Review 2.  Protein origami: therapeutic rescue of misfolded gene products.

Authors:  P Michael Conn; Alfredo Leaños-Miranda; Jo Ann Janovick
Journal:  Mol Interv       Date:  2002-09

3.  Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity.

Authors:  Francesca M Swords; Asma Baig; Diana M Malchoff; Carl D Malchoff; Michael O Thorner; Peter J King; László Hunyady; Adrian J L Clark
Journal:  Mol Endocrinol       Date:  2002-12

Review 4.  Therapeutic approaches to protein-misfolding diseases.

Authors:  Fred E Cohen; Jeffery W Kelly
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

5.  Characterization of an adrenocorticotropin (ACTH) receptor promoter polymorphism leading to decreased adrenal responsiveness to ACTH.

Authors:  Marc Slawik; Nicole Reisch; Oliver Zwermann; Christiane Maser-Gluth; Maik Stahl; Albrecht Klink; Martin Reincke; Felix Beuschlein
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

6.  Characterization of cell lines stably expressing human normal or mutated EGFP-tagged MC4R.

Authors:  Antonine Blondet; Mabrouka Doghman; Mohamed Rached; Philippe Durand; Martine Bégeot; Danielle Naville
Journal:  J Biochem       Date:  2004-04       Impact factor: 3.387

7.  Failed export of the adrenocorticotrophin receptor from the endoplasmic reticulum in non-adrenal cells: evidence in support of a requirement for a specific adrenal accessory factor.

Authors:  L A Noon; J M Franklin; P J King; N J Goulding; L Hunyady; A J L Clark
Journal:  J Endocrinol       Date:  2002-07       Impact factor: 4.286

8.  Heterogeneity in the molecular basis of ACTH resistance syndrome.

Authors:  Cristhianna Viesti Advincula Collares; Jose Antunes-Rodrigues; Ayrton Custodio Moreira; Suzana Nesi Franca; Luiz Alberto Pereira; Maria Marta Sarquis Soares; Jorge Elias Junior; Adrian J Clark; Margaret de Castro; Lucila Leico Kagohara Elias
Journal:  Eur J Endocrinol       Date:  2008-04-21       Impact factor: 6.664

9.  Clinical, genetic, and functional characterization of adrenocorticotropin receptor mutations using a novel receptor assay.

Authors:  Christa E Flück; John W M Martens; Felix A Conte; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

Review 10.  Quality control in the endoplasmic reticulum protein factory.

Authors:  Roberto Sitia; Ineke Braakman
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

View more
  24 in total

1.  "patients can have as many gene variants as they damn well please": why contemporary genetics presents us daily with a version of Hickam's dictum.

Authors:  Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2012-05       Impact factor: 5.958

Review 2.  The cAMP pathway and the control of adrenocortical development and growth.

Authors:  Cyrille de Joussineau; Isabelle Sahut-Barnola; Isaac Levy; Emmanouil Saloustros; Pierre Val; Constantine A Stratakis; Antoine Martinez
Journal:  Mol Cell Endocrinol       Date:  2011-10-15       Impact factor: 4.102

Review 3.  The year in G protein-coupled receptor research.

Authors:  Robert P Millar; Claire L Newton
Journal:  Mol Endocrinol       Date:  2009-12-17

Review 4.  Intracellular signaling mechanisms of the melanocortin receptors: current state of the art.

Authors:  Adriana R Rodrigues; Henrique Almeida; Alexandra M Gouveia
Journal:  Cell Mol Life Sci       Date:  2014-12-12       Impact factor: 9.261

5.  Mechanisms of melanocortin-2 receptor (MC2R) internalization and recycling in human embryonic kidney (hek) cells: identification of Key Ser/Thr (S/T) amino acids.

Authors:  Simon Roy; Sébastien Jean Roy; Sandra Pinard; Louis-Daniel Taillefer; Mohamed Rached; Jean-Luc Parent; Nicole Gallo-Payet
Journal:  Mol Endocrinol       Date:  2011-09-15

6.  Adrenocorticotropic Hormone (ACTH) Responses Require Actions of the Melanocortin-2 Receptor Accessory Protein on the Extracellular Surface of the Plasma Membrane.

Authors:  Sundeep Malik; Terrance M Dolan; Zachary J Maben; Patricia M Hinkle
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

7.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

8.  Familial glucocorticoid deficiency: a diagnostic challenge during acute illness.

Authors:  Abdelhadi M Habeb; Claire R Hughes; Rida Al-Arabi; Ali Al-Muhamadi; Adrian J L Clark; L A Metherell
Journal:  Eur J Pediatr       Date:  2013-05-26       Impact factor: 3.183

9.  Functional consequence of a novel Y129C mutation in a patient with two contradictory melanocortin-2-receptor mutations.

Authors:  Li F Chan; Teng-Teng Chung; Ahmed F Massoud; Louise A Metherell; Adrian J L Clark
Journal:  Eur J Endocrinol       Date:  2009-01-16       Impact factor: 6.664

10.  Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2.

Authors:  Teng-Teng L L Chung; Li F Chan; Louise A Metherell; Adrian J L Clark
Journal:  Clin Endocrinol (Oxf)       Date:  2009-06-24       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.